评审团队豪华:
Your revised paper was evaluated by a senior editor and discussed among all the editors here. It was also discussed with the Special Issue Guest Editors, and evaluated by two of the original reviewers, including a statistical reviewer.
编辑依然提了一大堆问题,竟然多达26条,不过都是小问题。
审稿人1对我的回复很满意,说:Reviewer #1: The authors have responded to each comment in turn, substantially rewording the manuscript where required.
本次去哦去除了composite score,第三个审稿人表示认可,没有其他意见了:
Reviewer #3: I appreciate your careful consideration of the composite of bullying and ultimate removal of the composite from the study.
主编说经其和其他编辑同事及学术编辑讨论后,修改语言编辑提的问题(8条)及出版事宜(就是提供推特账号)后,计划接收并发表我们的稿件:
I have discussed the paper with my colleagues and the academic editor. I am pleased to say that provided the remaining editorial and production issues are dealt with we are planning to accept the paper for publication in the journal.
看来已经成功说服了学术编辑。之前每轮都是大修,主编的措辞都是很扑朔迷离:
In light of the comments from the academic editor, we will not be able to accept the manuscript for publication in the journal in its current form, but we would like to consider a revised version that addresses the editors' comments. Obviously we cannot make any decision about publication until we have seen the revised manuscript and your response.
On behalf of my colleagues and the Academic Editor, I am pleased to inform you that we have agreed to publish your manuscript "Grade repetition and bullying victimization in adolescents: A global cross-sectional study of the Program for International Student Assessment (PISA) data from 2018" (PMEDICINE-D-21-00390R6) in PLOS Medicine’s Special Issue: Global Child Health: From Birth to Adolescence and Beyond.
今天下午(10/14/2021)进入Submissions in Production阶段,邮件标题是Required Modifications,主要是核对信息,一点小经验和教训,系统里有的,杂志会以系统为准。
We require you to make some technical changes to your manuscript, which are listed in the attached document. Your manuscript will not proceed to production until you have satisfactorily completed these requests.
今天上午(10/19/2021)收到邮件,标题是Update on your accepted manuscript at PLOS Medicine,主要是告知一下稿件已被正式接收,PLOS还敲了2篇,看来编辑也很激动哈:
I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS PLOS Medicine.
剩下就是等待proof review,选择的是Early Version,所以初稿会在正式稿之前上线:
The copy edited manuscript will be posted online ahead of the final proof version, unless you have already opted out of the process.